Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 30, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.3K

Methods for Analysis of Nanoparticle Immunosuppressive Properties.

Edward Cedrone1, Timothy M Potter1, Barry W Neun1

  • 1Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 20, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RNA-DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next-Generation Therapeutics.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Activation of an adaptive antitumor immune response by the polymeric fluoropyrimidine CF10 involves TS/Top1 dual targeting.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

When small gets smart: how the application of nanotechnology is transforming immunology in the 21<sup>st</sup> Century.

Nanomedicine (London, England)·2026
Same author

Comparative analyses for plant virus-based cancer immunotherapy drug development.

Cell biomaterials·2026
Same author

Expanding Chemical Space of Nucleic Acid Nanoparticles for Tunable Antiviral-Like Immunomodulatory Responses and Potent Adjuvant Activity.

Advanced functional materials·2026
Same author

Structure-function relationship of S protein cleavage in cowpea mosaic virus intratumoral immunotherapy.

Biomaterials science·2025

This study compares in vivo T cell dependent antibody response (TDAR) and in vitro human lymphocyte activation (HuLA) assays for assessing drug-induced immunosuppression, particularly for nanoparticles. The findings support using the HuLA assay as a viable alternative to TDAR in early drug development.

Area of Science:

  • Pharmacology
  • Immunotoxicology
  • Nanomedicine

Background:

  • Adverse drug effects on the immune system, specifically immunosuppression, are a major concern, leading to significant drug withdrawals.
  • Traditional methods like the T cell dependent antibody response (TDAR) assay are time-consuming and require substantial sample quantities.
  • Novel drug candidates necessitate efficient and reliable methods for early-stage immunotoxicity assessment.

Purpose of the Study:

  • To describe and compare the experimental procedures for evaluating nanoparticle immunosuppressive properties using both TDAR and HuLA assays.
  • To discuss the in vitro-in vivo correlation between the TDAR and HuLA methods.
  • To present a case study using an iron oxide nanoparticle formulation (Feraheme).

Main Methods:

Keywords:
AntigenHuLaImmunosuppressionLeukocyte proliferationNanoparticlesTDAR

More Related Videos

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
07:31

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry

Published on: March 28, 2014

17.6K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1&#945; Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.1K

Related Experiment Videos

Last Updated: Jun 30, 2025

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.3K
Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry
07:31

Detection of Fluorescent Nanoparticle Interactions with Primary Immune Cell Subpopulations by Flow Cytometry

Published on: March 28, 2014

17.6K
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1&#945; Nanoparticles
09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

2.1K
  • In vivo assessment using the T cell dependent antibody response (TDAR) assay with Keyhole Limpet Hemocyanin (KLH) antigen over 28 days.
  • In vitro assessment using the human lymphocyte activation (HuLA) assay with donor leukocytes, Fluzone, and nanoparticles, measuring antigen-specific lymphocyte proliferation via BrdU incorporation.
  • Enzyme-linked immunosorbent assay (ELISA) for measuring BrdU incorporation in the HuLA assay.
  • Main Results:

    • The study details the methodologies for both TDAR and HuLA assays in the context of nanoparticle immunotoxicity.
    • The in vitro-in vivo correlation between the two assays is discussed, highlighting the potential of the HuLA assay.
    • A case study involving Feraheme, an iron oxide nanoparticle, is presented to illustrate the application of these methods.

    Conclusions:

    • The human lymphocyte activation (HuLA) assay offers a promising in vitro alternative to the traditional T cell dependent antibody response (TDAR) assay for early preclinical assessment of drug-induced immunosuppression.
    • The HuLA assay is suitable for evaluating the immunomodulatory effects of nanoparticles.
    • Further validation and correlation studies are essential for refining the predictive value of in vitro assays in immunotoxicology.